Zum Hauptinhalt springen

Smartemis At a Glance

Traditional veterinary roll-ups promised security for clinic owners and returns for investors. In practice, they have delivered neither consistently. Veterinarians lose autonomy, culture erodes at scale, and financial engineering has its limits. Smartemis was built as a direct response to these failures — offering a model where independence and collective strength are not a trade-off, but a combination.

Dr Schmidt Frida

Smartemis Network Year-on-Year Growth

Since 2022, the clinic network has expanded from 2 clinics in Q2-2022 to 131 clinics in Q4-2025, reflecting market-leading growth.

The network achieved an average quarter-over-quarter growth rate of approximately 39%, demonstrating sustained momentum in new clinic adoption.

This rapid expansion translates into a 205% compound annual growth rate (CAGR) over the period, highlighting the scalability of the model and the accelerating demand across the market.

0
50
100
150
200
2
Q2
2022
4
Q3
2022
10
Q4
2022
14
Q1
2023
20
Q2
2023
26
Q3
2023
40
Q4
2023
48
Q1
2024
61
Q2
2024
71
Q3
2024
97
Q4
2024
108
Q1
2025
113
Q2
2025
124
Q3
2025
131
Q4
2025
2022
10
Year-end value
2023
40
Year-end value
2024
97
Year-end value
2025
131
Year-end value

The Problem

The Traditional “Buy and Builds” is Risky for Veterinarians

  • When a veterinarian becomes a salaried employee within a corporate group, much of that professional autonomy fades.
  • Decisions that were once made independently — from pricing to clinical approach — are increasingly shaped by centralized management and financial targets.
  • Strategic priorities tend to align with revenue goals and standardized processes rather than purely clinical judgment or community relationships. Ownership becomes employment, and what was once a self-directed practice becomes part of a larger system where control ultimately sits elsewhere.

It’s Also Not Working for Investors

  • The easy financial engineering phase of roll-ups is coming to an end as markets become saturated, making it harder to replicate early gains.
  • At the same time, margin compression is increasing, and EBITDA improvements are becoming more difficult to sustain over time. Many clinics are starting to feel overly corporatized, and culture simply doesn’t scale the way spreadsheets do.
  • On top of that, exit risk is rising: if growth slows or regulation tightens, exit multiples could compress, putting additional pressure on returns.

Smartemis solution

This Is Where Smartemis Becomes Powerful

Smartemis is more than a network of independent clinics — it is a shared infrastructure platform, a collective intelligence system, and a true negotiation force. While staying alone preserves independence but creates isolation, and selling to a group offers security at the cost of control, joining Smartemis delivers both: full independence combined with collective strength.

By connecting ambitious clinics through shared tools, expertise, and strategy, Smartemis enhances bargaining power and acts as a strategic shield against corporatization — empowering clinics to grow, compete, and thrive on their own terms.

Doctor clicking picture
Smartemis at a Glance | Europe's Fastest-Growing Independent Vet Network